Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial.
Saved in:
| Title: | Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. |
|---|---|
| Authors: | Stewart S; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Seco-Meseguer E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Diago-Sempere E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Marín-Candón A; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Carmona M; Unidad de Investigación en Telemedicina y e-Salud, Instituto de Salud Carlos III, Madrid, Spain., Estébanez M; Internal Medicine Department, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain., López-Fernández LA; Pharmacy Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain.; Plataforma SCReN (Spanish Clinical Research Network), Madrid, Spain., Imaz-Iglesia I; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain., Del Mar García Saiz M; Clinical Pharmacology Service, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain., Laserna-Mendieta EJ; Department of Gastroenterology, Research Unit, Hospital General de Tomelloso, Tomelloso, Castilla-La Mancha, Spain.; Instituto de Investigación Sanitaria de Castilla La Mancha, Toledo, Castilla La Mancha, Spain., Peiró AM; Unidad de Farmacología Clínica, Unidad del Dolor, Alicante Department of Health-General Hospital, Alicante, Comunidad Valenciana, Spain., Farré M; Department of Clinical Pharmacology, Pharmacogenomics Unit, Hospital Germans Trias i Pujol, Badalona, Catalunya, Spain.; Department of Pharmacology, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalunya, Spain., Rodriguez-Jimenez C; Clinical Trials Unit, Pharmacology Department, Hospital Universitario de Canarias, La Laguna, Canarias, Spain.; Complejo Hospital Universitario de Canarias, UICEC, La Laguna, Spain., Saiz-Rodriguez M; Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain., Sanabria-Cabrera J; Servicio de Farmacología Clínica, IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain, Platform for Clinical Research and Clinical Trials IBIMA, Hospital Universitario Virgen de la Victoria, Malaga, Andalucía, Spain., Rosas-Alonso R; Pharmacogenetics Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain., Abad-Santos F; UICEC Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Pedrosa L; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., García García I; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain alberto.borobia@salud.madrid.org.; Pharmacology Department. School of Medicine, Autonomous University of Madrid, Madrid, Spain. |
| Corporate Authors: | iPHARMGx study group |
| Source: | BMJ open [BMJ Open] 2024 Nov 07; Vol. 14 (11), pp. e089823. Date of Electronic Publication: 2024 Nov 07. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39510769 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stewart+S%22">Stewart S</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Seco-Meseguer+E%22">Seco-Meseguer E</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Diago-Sempere+E%22">Diago-Sempere E</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marín-Candón+A%22">Marín-Candón A</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carmona+M%22">Carmona M</searchLink>; Unidad de Investigación en Telemedicina y e-Salud, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Estébanez+M%22">Estébanez M</searchLink>; Internal Medicine Department, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-Fernández+LA%22">López-Fernández LA</searchLink>; Pharmacy Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain.; Plataforma SCReN (Spanish Clinical Research Network), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Imaz-Iglesia+I%22">Imaz-Iglesia I</searchLink>; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Mar+García+Saiz+M%22">Del Mar García Saiz M</searchLink>; Clinical Pharmacology Service, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.<br /><searchLink fieldCode="AU" term="%22Laserna-Mendieta+EJ%22">Laserna-Mendieta EJ</searchLink>; Department of Gastroenterology, Research Unit, Hospital General de Tomelloso, Tomelloso, Castilla-La Mancha, Spain.; Instituto de Investigación Sanitaria de Castilla La Mancha, Toledo, Castilla La Mancha, Spain.<br /><searchLink fieldCode="AU" term="%22Peiró+AM%22">Peiró AM</searchLink>; Unidad de Farmacología Clínica, Unidad del Dolor, Alicante Department of Health-General Hospital, Alicante, Comunidad Valenciana, Spain.<br /><searchLink fieldCode="AU" term="%22Farré+M%22">Farré M</searchLink>; Department of Clinical Pharmacology, Pharmacogenomics Unit, Hospital Germans Trias i Pujol, Badalona, Catalunya, Spain.; Department of Pharmacology, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Jimenez+C%22">Rodriguez-Jimenez C</searchLink>; Clinical Trials Unit, Pharmacology Department, Hospital Universitario de Canarias, La Laguna, Canarias, Spain.; Complejo Hospital Universitario de Canarias, UICEC, La Laguna, Spain.<br /><searchLink fieldCode="AU" term="%22Saiz-Rodriguez+M%22">Saiz-Rodriguez M</searchLink>; Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain.<br /><searchLink fieldCode="AU" term="%22Sanabria-Cabrera+J%22">Sanabria-Cabrera J</searchLink>; Servicio de Farmacología Clínica, IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain, Platform for Clinical Research and Clinical Trials IBIMA, Hospital Universitario Virgen de la Victoria, Malaga, Andalucía, Spain.<br /><searchLink fieldCode="AU" term="%22Rosas-Alonso+R%22">Rosas-Alonso R</searchLink>; Pharmacogenetics Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Abad-Santos+F%22">Abad-Santos F</searchLink>; UICEC Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pedrosa+L%22">Pedrosa L</searchLink>; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carcas+AJ%22">Carcas AJ</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García+García+I%22">García García I</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Borobia+AM%22">Borobia AM</searchLink>; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain alberto.borobia@salud.madrid.org.; Pharmacology Department. School of Medicine, Autonomous University of Madrid, Madrid, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22iPHARMGx+study+group%22">iPHARMGx study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552874%22">BMJ open</searchLink> [BMJ Open] 2024 Nov 07; Vol. 14 (11), pp. e089823. <i>Date of Electronic Publication: </i>2024 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101552874 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-6055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220446055%22">20446055 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39510769 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bmjopen-2024-089823 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e089823 Titles: – TitleFull: Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stewart S – PersonEntity: Name: NameFull: Seco-Meseguer E – PersonEntity: Name: NameFull: Diago-Sempere E – PersonEntity: Name: NameFull: Marín-Candón A – PersonEntity: Name: NameFull: Carmona M – PersonEntity: Name: NameFull: Estébanez M – PersonEntity: Name: NameFull: López-Fernández LA – PersonEntity: Name: NameFull: Imaz-Iglesia I – PersonEntity: Name: NameFull: Del Mar García Saiz M – PersonEntity: Name: NameFull: Laserna-Mendieta EJ – PersonEntity: Name: NameFull: Peiró AM – PersonEntity: Name: NameFull: Farré M – PersonEntity: Name: NameFull: Rodriguez-Jimenez C – PersonEntity: Name: NameFull: Saiz-Rodriguez M – PersonEntity: Name: NameFull: Sanabria-Cabrera J – PersonEntity: Name: NameFull: Rosas-Alonso R – PersonEntity: Name: NameFull: Abad-Santos F – PersonEntity: Name: NameFull: Pedrosa L – PersonEntity: Name: NameFull: Carcas AJ – PersonEntity: Name: NameFull: García García I – PersonEntity: Name: NameFull: Borobia AM IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 11 Text: 2024 Nov 07 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2044-6055 Numbering: – Type: volume Value: 14 – Type: issue Value: 11 Titles: – TitleFull: BMJ open Type: main |
| ResultId | 1 |
